Kraig Biocraft Laboratories announces Commercial Production Update
The Company began production operations, at its Vietnamese subsidiary, in October of 2019. Due to climate conditions and farming cycles, silk is traditionally not produced during the winter in Vietnam. In its efforts to bring its revolutionary silk materials to market, as soon as possible, the Company pushed ahead, rearing its silkworms through the winter months.
The Company hoped to overcome the production challenges of operating in the off season by utilizing its temperature controlled laboratories. While initially highly successful, the Company began to face setbacks in sustaining production during this traditional off season. Fluctuating temperatures, and difficulties in sourcing high quality mulberry, led to production challenges. The Company has accelerated the planting of additional mulberry under contract and control to eliminate these issues for future production cycles.
The Company expects to re-ignite its production expansion over the next 30-45 days, as spring temperatures realign with production requirements. The Company will also use this growing season as an opportunity to improve its internal factory environmental control protocols. When all controls are in place, the Company believes that it can successfully reach year-round production.
“As with any company’s first large scale production run, we expected some delays and challenges. These small hurdles will cause a short delay, but we do not anticipate any negative impact to our long term plans, quality, or capacity,” said Jon Rice, COO. “We assembled an excellent team in Vietnam; they are tirelessly working to bring this vision of large scale spider silk production, from silkworms, to life. I am excited about the opportunities ahead for Kraig Labs and our eco-friendly spider silk materials.”
The outbreak of Coronavirus in China is not presently expected to have any significant impact on the Company or its operations. The Company does not source any materials or import from China, nor is China a major target market for the Company’s products.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
Source: Kraig Biocraft Laboratories, Inc.